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A B S T R A C T   
Background: This study aimed to evaluate the heterogeneous association of depressive subtypes with cognitive 
function, according to age and sex. 
Methods: This cross-sectional study utilized the baseline data from the Cardiovascular and Metabolic Disease 
Etiology Research Center cohort and included 5271 midlife participants. For identifying depressive subtypes of 
the Beck Depression Inventory II items, factor analyses were utilized and yielded two factors —melancholic- and 
somatic-depressive subtypes. The information of Mini-Mental State Examination was used for screening cognitive 
function. The association between depressive subtypes and cognitive function was analysed using multiple 
regression after adjusting for all covariates. 
Results: We observed heterogeneous association between depressive subtypes and cognitive dysfunction in 
midlife participants. The results of sex- and age- stratified analyses indicated that the somatic subtype was 
associated with dysfunction in cognitive ability. Among women, especially those aged over 60 years, MMSE 
scores decreased as the somatic depression scores increased. These results might suggest that the somatic sub-
type, rather than the melancholic subtype, has a greater association with cognitive assessment in a general 
midlife population, particularly older women. 
Limitations: Although a confirmatory factor analysis was performed, depressive subtypes need validation and 
reliability tests. 
Conclusions: Given this heterogeneity, characterisation of depressive subtypes according to sex and age may 
improve our understanding of how each depressive symptom is associated differently with cognitive dysfunction 
in midlife.   
1. Introduction 
Leading to poor quality of life and even mortality, dementia among 
older adults poses a considerable burden on public health. Worldwide, 
approximately 50 million people are diagnosed with dementia (Living-
ston et al., 2020; Ponjoan et al., 2019), and research suggests that by 
2050, this number will grow to about 152 million people (Livingston 
et al., 2020). Overall, a growing body of studies suggest that potentially 
modifiable risk factors for dementia (e.g., depression) might be associ-
ated with cognitive deficits (Livingston et al., 2020). Thus, addressing 
risk factors for depression might be positively modifiable for cognitive 
function among older adults. 
A number of previous studies have indicated that depression is not a 
homogeneous entity and requires personalized characterisation of 
symptom profiles (Maj, 2018; Maj et al., 2020). According to the 
Diagnostic and Statistical Manual of Mental Disorders-5, depression 
diagnosis relies on the identification of a number of key symptoms, the 
primary being emotional symptoms, then neurovegetative symptoms, 
and finally, neurocognitive symptoms (APA 2013). However, symptoms 
can span several domains, and which symptoms warrant priority re-
mains unclear (Malhi and Mann, 2018). Clinically, melancholic and 
non-melancholic/atypical subtypes are classified as the core subtypes of 
depressive symptoms, and are considered as diagnostic specifier of 
depression (Maj et al., 2020; Uher et al., 2011). Notwithstanding, some 
depression screening assessments, such as the Beck Depression Inven-
tory-II (BDI-II), account for varying symptoms that can be divided into 
two or more subtypes: among them, the most frequently noted subtypes 
of depressive symptoms are categorized as ‘cognitive’, ‘affective’, and 
‘somatic’ (Jeon et al., 2020; Manian et al., 2013; Arnau et al., 2001; 
Steer and Clark, 1997; Huang and Chen, 2015; Gary et al., 2018). 
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Cognitive deficit is considered a core dimension of depressive 
symptoms (McIntyre et al., 2013), and research has shown a link be-
tween depression severity, depressive subtype, and cognitive perfor-
mance (Austin et al., 2001). Among neuropathological deficits of 
cognitive function, verbal and visual memory domains, in particular, are 
associated with depressive subtypes (Austin et al., 2001). These findings 
have been reported in all age groups, although more frequently in older 
participants (McDermott and Ebmeier, 2009; Shimada et al., 2014). 
Furthermore, depressive symptoms contributed significantly to the 
explained variance by sex and age interactions, and which may have 
additional impact on the lifestyle factors (McDermott and Ebmeier, 
2009; Daig et al., 2009). However, available results are conflicting 
(McDermott and Ebmeier, 2009). Therefore, our study was designed to 
investigate associations among depressive subtypes and cognitive 
function according to age and sex. 
2. Methods 
2.1. Data collection and participants 
This cross-sectional study utilized baseline data from the Cardio-
vascular and Metabolic Disease Etiology Research Center (CMERC) 
cohort and initially included 8097 participants. We excluded individuals 
who did not respond to the BDI-II questionnaires, were under 50 years of 
age, and did not undergo Mini-Mental State Examination (MMSE) 
screening for dementia. Finally, this study included 5271 individuals for 
analysis, totalling 1684 men and 3567 women. 
2.2. Assessing depressive symptoms and defining depressive subtypes 
In the CMERC cohort, BDI-II was administered to measure the 
severity of depression over the previous 2 weeks. This questionnaire was 
conducted as a self-assessment measure. It was not designed to generate 
a diagnosis of major depressive disorders, but to screen for depressive 
symptoms in non-diagnosed populations or to identify the intensity of 
diagnosed depressive episodes (Lim et al., 2011). BDI-II, which has been 
validated in the Korean population (Lim et al., 2011), consisted of 21 
self-rated items about depressive symptoms. Each item is rated on a 
4-point scale from 0 to 3, and the total sum of the questionnaires ranges 
from 0 to 63, with total scores indicating depression levels as follows: 
0–13 = ‘minimal’, 14–19 = ‘mild’, 20–28 = ‘moderate’, and 29–63 =
‘severe’. 
To investigate depressive subtypes with BDI-II items, we performed 
exploratory factor analysis on the basis of previous studies (Jeon et al., 
2020; Manian et al., 2013; Gary et al., 2018). Among them, one study 
utilizing the same data source as our study (i.e., the data from the 
CMERC cohort) suggested two latent factors from the BDI-II items and 
categorized them as ‘cognitive’ (items 1 to 3 and 5 to 11) and ‘somati-
c-affective’ (items 4, 12, 13, and 15 to 21) factors (Jeon et al., 2020). 
Similarly, in our study, we defined two subtypes: ‘melancholic’ 
depressive factors (factor 1) and ‘somatic’ depressive factors (factor 2). 
Melancholic depressive factors included 12 items (BDI-II items 1 to 11 
and 14), while somatic included nine items (BDI-II items 12, 13, and 15 
to 21). In addition, depressive subtype scores were subdivided into 
quartiles. By considering the quartiles, our study reported differences 
between the lowest verses each of the three higher quartiles of depres-
sive subtype scores in order to aid in the interpretation of our findings 
and examined whether cognitive function decreased as depressive sub-
type scores increased. 
2.3. Cognitive function assessed by the MMSE 
In our study, participants aged over 50 years responded to MMSE 
questionnaires for cognitive assessment. In community and primary 
care, screening tools, such as the MMSE and Montreal Cognitive 
Assessment, is utilized for the purpose of mapping out levels of cognitive 
function (Ismail et al., 2010). However, these are sometimes 
under-diagnosed in older adults (Ismail et al., 2010). Despite significant 
limitations, MMSE remains the most frequently used cognitive screening 
instrument in community populations (Ismail et al., 2010). The MMSE 
has been verified in the Korean population, with inter-rater reliability 
and test and retest reliability values of 0.999 (p < 0.001) and 0.935 (p <
0.001), respectively (Kim et al., 2010; Han et al., 2010). The MMSE 
contained 19 items and evaluated state of cognitive function in orien-
tation, verbal memory, concentration and calculation, language, praxis, 
and visuospatial construction domains. The total sum of the examination 
ranges from 0 to 30, with lower total scores indicating cognitive deficit. 
The cut-off score of the MMSE for screening for cognitive deficit is 
traditionally 24 points; however, we calculated total scores as contin-
uous variables in our study (Folstein et al., 1983; Kukull et al., 1994). 
2.4. Covariates 
Covariates included age, sex, socio-economic status, lifestyle factor, 
disease history, and current medication intake. Socio-economic status 
reflected marital status, educational year, and household income level. 
Marital status was classified as never married, living together with a 
partner, living alone, and separation due to death of a partner. Infor-
mation on educational years was categorized as 6 years or less (under 
elementary school), 9 years or less (under middle school), 12 years or 
less (under high school), and over 12 years (more than college). 
Household income was measured as quartiles on a cumulative distri-
bution (i.e., the lowest was the first quartile and the highest was the 
fourth quartile). Lifestyle factors included smoking, alcohol consump-
tion, and physical activity. Smoking and alcohol consumption was 
categorized as never, past, and currently smoking or drinking. Physical 
activity was measured by self-responses and categorized into three 
groups based on both amount and intensity of regular exercise per week: 
‘low’, if people never exercised; ‘middle’, if people exercised less than 
150 min, and ‘high’, if people exercised more than 150 min at moderate 
to vigorous activity during the week on an average. Disease history was 
assessed via self-administered questionnaires surveying diagnoses by 
physicians during each participant’s lifetime. The list of diseases was as 
follows: hypertension, any kind of cancer, diabetes, stroke, myocardial 
infarction, angina, heart failure, chronic renal failure, dyslipidaemia, 
liver disease, chronic hepatitis, liver cirrhosis, thyroid disorders, 
asthma, chronic obstructive pulmonary disease, osteoporosis, arthritis, 
and autoimmune disease. A comorbid condition was categorized as ‘yes’ 
if the participants responded that they had been diagnosed with any of 
these diseases, otherwise, it was categorized as ‘no’. Current medication 
intake was indicated as ‘yes’ if the respondents indicated they took a 
medication prescribed by a physician due to any comorbid condition(s); 
otherwise, it was recorded as ‘no’. 
3. Statistical analysis 
Population characteristics according to cognitive deficit were 
assessed using the chi-square test and t-test. The two latent subtypes 
based on BDI-II were classified utilizing exploratory factor analysis with 
varimax rotation. Factor loading for exploratory factor analysis to sort 
the factors was 0.40. Factor 1 included items 1 to 11 and 14 (i.e., 
‘melancholic’ factors), and factor 2 consisted of items 12, 13, and 15 to 
21 (i.e., ‘somatic’ factors). Following the exploratory factor analysis, 
factor scores was constructed using weighted sum scores, which could 
take into consideration the loading values in the factor score creation 
and recognize the strength for items (DiStefano et al., 2009). Consid-
ering the factor loading values of each item, weighted sum scores were 
assessed by multiplying loading values of each item to the raw data, after 
standardizing the items to the same mean and standard deviation items 
(DiStefano et al., 2009). The associations between depressive subtypes 
and cognitive function were analysed using multiple regression with a 
generalised linear model to determine coefficients (βs) and standard 
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errors (SEs). Each model was regressed including a series of independent 
variables (melancholic and somatic subtypes) and covariates (sex, age, 
socio-economic status, lifestyle factors, disease history, and medication 
intake). Stratified analyses were performed by age and sex (see Fig. S1). 
P values < 0.05 were considered statistically significant. Bonferroni 
correction was additionally applied for multiple comparisons of quar-
tiles of depressive subtype scores (significance P values < 0.0125). All 
statistical analyses were performed using SAS software, version 9.4 (SAS 
Institute Inc., Cary, NC, USA). 
4. Results 
4.1. Characteristics of the study population according to cognitive 
function 
Table 1 shows the characteristics of the study population according 
to cognitive function. The total number of participants included in this 
study was 5271. Of the 787 individuals with cognitive deficit, 577 were 
women, and 210 were men. For the cognitive deficit group, the mean 
age was approximately 57.4 years, which was relatively higher than that 
of the normal group (56.8 years), and most had less than 12 years of 
education. Additionally, in the cognitive deficit group, total BDI-II 
scores (mean score of 12.6) and subtotal scores for both melancholic 
(mean score of 5.3) and somatic (mean score of 7.3) factors tended to 
show higher mean scores and significant differences, compared to the 
normal group (p-for difference <0.01). 
4.2. Associations between depressive subtypes and cognitive assessment 
according to sex 
The sex-specific associations between depressive subtypes and 
cognitive assessment according to quartiles of depressive symptoms are 
listed in Table 2. Among depressive subtypes, somatic scores were 
associated with decreased cognitive assessment than melancholic scores 
in both sexes: for a 1-unit increase in the score of somatic subtypes, the 
coefficient of the MMSE scores were likely to decrease. In addition, both 
sexes reported a significant tendency for lower MMSE scores when so-
matic scores increased (somatic score; in men, p for trend=0.04; in 
women, p for trend=<0.01), whereas the same trend in BDI-II scores was 
observed only in women (see Table S1 and Fig. S2). Considering quar-
tiles of the somatic subtypes, in women, higher quartiles of somatic 
subtotal scores were more strongly associated with lower MMSE scores 
in succession, with significance mainly in the somatic quartile. 
Compared to the lowest 25% (Q1) of somatic subtotal scores, the highest 
25% (Q4) tended to lower the coefficient of MMSE scores by 0.50 per 
unit increase in somatic subtotal scores; the third quartile (Q3) lowered 
it by 0.39; and the second quartile (Q2) lowered it by 0.37 (Q2: β=-0.37, 
p < 0.01; Q3: β=-0.39, p < 0.01; Q4: β=-0.50, p < 0.001). However, in 
men, there were no significant results for MMSE results according to 
quartiles of somatic subtype scores. 
4.3. Associations between depressive subtypes and cognitive assessment 
according to age 
The age-stratified associations between depressive subtypes and 
cognitive assessment according to quartiles of depressive symptoms are 
provided in Table 3. In midlife participants older than 50 years, higher 
BDI-II scores were associated with a dysfunction in cognitive assessment 
(see Table S2 and Fig. S3). Only the somatic subtype tends to show an 
association with lower cognitive assessment (age >50 years, p for 
trend<0.01; age >60 years, p for trend<0.01). In the somatic subtype, 
dysfunction seemed to be greater in individuals older than 60 years than 
in those in their 50s (age >50 years, β=-0.17, p < .01; age >60 years, 
β=-0.21, p = 0.01). However, in comparison with the lowest quartile of 
somatic scores (the least depressed), those in the highest quartile 
showed a greater dysfunction in MMSE scores, although most of the 
estimates were not significant in all age groups. 
4.4. Associations between depressive subtypes and cognitive assessment 
according to sex and age 
Table 4 shows the results of stratified analyses according to sex and 
age for the associations between depressive subtypes and cognitive 
assessment in a midlife population. In women older than 50 years, 
higher scores on BDI-II were associated with a dysfunction in cognitive 
assessment (see Table S3 and Fig. S4). In women over 50 years, the 
somatic subtype tends to show an association with dysfunction in MMSE 
score. Given the quartiles of depressive symptoms, the more depressed 
participants appeared to have significantly lower MMSE scores, only in 
women (somatic score; in women of 50 years, p for trend<0.01; in 
women over 60 years, p for trend=0.01). Dysfunction seemed to be more 
robust in women older than 60 years, compared to those in their 50s (in 
50 years, β=-0.18, p < 0.01; in over 60 years, β=-0.25, p = 0.02). 
Table 1 







BDI-II score, Mean(SD) 10.4 (7.4) 12.6 (8.5) <0.01 
Sex, N (%)     <0.01 
Men 1494 (33.3) 210 (26.7)  
Women 2990 (66.7) 577 (73.3)  
Age, Mean (SD) 56.8 (3.9) 57.4 (3.9) <0.01 
Marital status, N (%)     0.06 
Never married 46 (1.0) 3 (0.4)  
Living together 3945 (88.0) 680 (86.4)  
Living alone 56 (1.3) 8 (1.0)  
Divorced or widowed 437 (9.8) 96 (12.2)  
Education, N (%)     <0.01 
≤ 6 years 286 (6.4) 117 (14.9)  
≤ 9 years 518 (11.6) 210 (26.7)  
≤ 12 years 2103 (46.9) 346 (44.0)  
> 12 years 1577 (35.2) 114 (14.5)  
Household Income, N (%)     <0.01 
Q1 (Low 25th percentile) 1142 (25.5) 303 (38.5)  
Q2 140 (31.2) 239 (30.4)  
Q3 750 (16.7) 113 (14.4)  
Q4 (High 25th percentile) 1191 (26.6) 132 (16.8)  
Smoking, N (%)      
Never 3212 (71.6) 606 (77.0) <0.01 
Past 879 (19.6) 115 (14.6)  
Current 393 (8.8) 66 (8.4)  
Drinking, N (%)     <0.01 
Never 1299 (29.0) 252 (32.0)  
Past 189 (4.2) 17 (2.2)  
Current 2996 (66.8) 518 (65.8)  
Regular exercise, N (%)     <0.01 
Low (0 min/per week) 2219 (49.5) 468 (59.5)  
Middle (less 150 min/per week) 541 (12.1) 94 (11.9)  
High (over 150 min/per week) 1724 (38.5) 225 (28.6)  
Disease historyc, N (%)     0.61 
No 1996 (44.5) 358 (45.5)  
Yes 2488 (55.5) 429 (54.5)  
Current medication intake, N (%)    0.37 
No 2380 (53.1) 404 (51.3)  
Yes 2104 (46.9) 383 (48.7)  
Notes. Sum of numbers may not reflect the total number in group due to missing 
values. 
a Normal reflect the participants with a score of 24 or more in the Mini-Mental 
State Examination. 
b Cognitive deficit reflect the participants with a score of less than 24 in the 
Mini-Mental State Examination. 
c Disease history include the diagnosed experiences of hypertension, any kinds 
of cancer, diabetes, stroke, myocardial infarction, angina, heart failure, chronic 
renal failure, dyslipidemia, liver diseases, chronic hepatitis, and liver cirrhosis, 
thyroid disorders, asthma, and chronic obstructive pulmonary disease, osteo-
porosis, arthritis, and autoimmune disease. 
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5. Discussion 
This study showed varying associations between two depressive 
subtypes (melancholic versus somatic factors) and cognitive assessment 
in a general midlife population. The results of sex- and age- stratified 
analyses indicated that the somatic subtype was associated with cogni-
tive dysfunction. Among women, especially those aged over 60 years, 
MMSE scores decreased as the somatic depression scores increased. 
These results might suggest that the somatic subtype, rather than the 
melancholic subtype, has a greater association on cognitive assessment 
in a general midlife population, particularly older women. 
Research suggests that if depressive symptoms and cognitive deficits 
occur at the same time, the cognitive dysfunction tends to persist even 
after the symptoms of depression are relieved (Hasselbalch et al., 2011; 
Ahern and Semkovska, 2017). Furthermore, some studies have shown 
that approximately 40% of currently or formerly depressed participants 
have experienced concurrent cognitive deficits (Gualtieri and Morgan, 
2008; LeMoult and Gotlib, 2019). Some preliminary experimental 
studies have indicated that mood-related cognitive deficits often 
accompany specific domains of cognitive deficits, such as problems in 
the memory domains (LeMoult and Gotlib, 2019; Whitmer and Gotlib, 
2013). Indeed, depression-related decreases in cognitive function, 
especially attention and/or interpretation functions, are considered as a 
part of the depressive symptoms, and the severity of depression is well 
correlated with greater cognitive impairment (APA 2013; Lezak et al., 
2004; Everaert et al., 2017). 
It is well-recognized that cognitive function, comprising various 
domains, is not a unitary construct and that each specific domain is 
associated differently with risk factors, such as sex, sociodemographic 
variables, depression, vascular risk, APOE-e4, and others (MacAulay 
et al., 2020; Singh-Manoux et al., 2010). Moreover, considering the hi-
erarchy among key depressive symptoms, such as emotional, neuro-
vegetative, and neurocognitive symptoms, this depressive hierarchy 
could diversely interact with each cognitive domain (Malhi and Mann, 
2018; Uher et al., 2011). In our study, these depressive symptoms were 
categorized by using factor analysis as melancholic and somatic factors, 
and the heterogeneous subtypes interacted differently with cognitive 
dysfunction. However, it remains unclear which subtype has a greater 
weighting than the other subtype (Malhi and Mann, 2018; Uher et al., 
2011). Therefore, further longitudinal study might be required to 
Table 2 
Sex-specific associations between depressive subtypes and MMSE scores according to depressive subtypes quartiles.   
MMSE scores  
Men (N ¼ 1704) Women (N ¼ 3567)  
N βa (SE) p-value p for trend N βa (SE) p-value p for trend 
BDI-II scores 1704 -0.02 (0.01) 0.01  3567 -0.03 (0.01) <0.01  
Melancholic scores  -0.08 (0.08) 0.32   -0.14 (0.05) <0.01  
Q1 356 ref  0.79 962 ref  0.02 
Q2 485 0.47 (0.17) 0.01*  833 -0.08 (0.12) 0.52  
Q3 444 0.07 (0.17) 0.68  873 -0.09 (0.12) 0.43  
Q4 419 0.15 (0.18) 0.40  899 -0.30 (0.12) 0.01*  
Somatic scores  -0.16 (0.08) 0.04   -0.20 (0.05) <0.01  
Q1 603 ref  0.04 715 ref  <0.01 
Q2 487 0.30 (0.15) 0.04  824 -0.37 (0.13) <0.01*  
Q3 372 -0.13 (0.16) 0.42  952 -0.39 (0.13) <0.01*  
Q4 242 -0.19 (0.19) 0.32  1076 -0.50 (0.13) <0.01*  
Notes. Coefficients were adjusted for age, socio-economic status (marital status, education, household income), life style (smoking, drinking, regular exercise), disease 
history and medication intake. 
“Melancholic” and “somatic” subtypes of BDI-II were derived from factor analysis of study participants. 
Q1: first quartile (low 25th percentile); Q2: second quartile; Q3: third quartile; Q4 fourth quartile (high 25th percentile) 
a β: Coefficients adjusted for all covariates. 
* Significant in Bonferroni correction. 
Table 3 
Age-specific associations between depressive subtypes and MMSE scores according to depressive subtypes quartiles.   
MMSE scores  
50 years (N ¼ 3774) Over 60 years (N ¼ 1497)  
N βa (SE) p-value p for trend N βa (SE) p-value p for trend 
BDI-II scores 3774 -0.03 (0.01) <0.01  1497 -0.03 (0.01) <0.01  
Melancholic scores  -0.12 (0.05) 0.01   -0.13 (0.08) 0.10  
Q1 962 ref  0.06 356 ref  0.30 
Q2 941 0.00 (0.12) 0.99  377 0.27 (0.19) 0.16  
Q3 954 -0.10 (0.11) 0.36  363 0.02 (0.19) 0.90  
Q4 917 -0.20 (0.12) 0.08  401 -0.13 (0.19) 0.51  
Somatic scores  -0.17 (0.05) <0.01   -0.21 (0.09) 0.01  
Q1 932 ref  <0.01 386 ref  <0.01 
Q2 949 -0.11 (0.12) 0.36  362 -0.07 (0.19) 0.71  
Q3 961 -0.24 (0.12) 0.04  363 -0.30 (0.19) 0.13  
Q4 932 -0.31 (0.12) 0.01*  386 -0.47 (0.20) 0.02  
Notes. Coefficients were adjusted for age, socio-economic status (marital status, education, household income), life style (smoking, drinking, regular exercise), disease 
history and medication intake. 
“Melancholic” and “somatic” subtypes of BDI-II were derived from factor analysis of study participants. 
Q1: first quartile (low 25th percentile); Q2: second quartile; Q3: third quartile; Q4 fourth quartile (high 25th percentile) 
a β: Coefficients adjusted for all covariates. 
* Significant in Bonferroni correction. 
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explore if the hierarchy exists even in depressive subtypes and which 
subtypes would be greater on cognitive function. 
Additionally, our study showed that somatic factors elicited a greater 
likelihood of cognitive deficits in women over the age of 60 years; 
however, we could not find any significant results for any age range in 
men. This result highlights the importance of identifying different roles 
of depressive subtypes in cognitive function according to sex. In fact, 
there is a well-founded association between sex hormone and cognitive 
function and depression (Castanho et al., 2014; Wolf and Kirschbaum, 
2002). Through aging, changes mediated by declines in sex-related 
hormones, especially estradiol, have been shown to be associated with 
lower overall cognition and depression (Castanho et al., 2014; Wolf and 
Kirschbaum, 2002). A progressive decline in sex hormone with age is 
more noticeable in women than in men, especially post menopause, and 
lower concentrations of dehydroepiandrosterone, a precursor of sex 
hormone, appears to be associated with a more pronounced decrease in 
cognitive function and an overall depressed mood (Castanho et al., 
2014; Wolf and Kirschbaum, 2002; Davis et al., 2011; Harsh et al., 
2009). These cited studies may provide some explanation for our results. 
However, to our knowledge, no study has taken a fine-grained approach 
to investigate the impact of various depressive subtypes on cognitive 
function in a midlife adult population based on sex. The mechanisms 
behind the effects of depressive subtypes on cognitive function accord-
ing to sex remain to be further explored. 
Depression has been shown to be broadly related to poor cognitive 
function in older adults (Singh-Manoux et al., 2010; Bassuk et al., 1998; 
Paterniti et al., 2002). Depression in older adults may occur as an 
extension of their experiences as adolescents. Due to cumulated 
sex-differenced experiences of stressful life events and other risk factors 
from adolescence, there may exist a possibility for greater cognitive 
deficits and higher prevalences of depressive symptoms in older women 
(Wolf and Kirschbaum, 2002; Hamilton et al., 2015; Abela and Hankin, 
2009). In addition, some longitudinal studies have indicated that the 
emergence of sex differences in depression occurs in early adolescence 
and continues into adulthood (Hamilton et al., 2015; Hankin et al., 
1998). Several longitudinal studies from the UK and France, on late 
midlife, have examined the association between history and frequency 
of depressive symptoms using the General Health Questionnaire or 
Center for Epidemiologic Study Depression scale and cognitive deficits 
using the MMSE (Singh-Manoux et al., 2010; Paterniti et al., 2002). They 
suggested that depressive episodes tend to cluster in individuals and that 
individuals with persistent depressive symptoms face a greater risk of 
cognitive deficits in late midlife (Singh-Manoux et al., 2010; Paterniti 
et al., 2002). However, this interpretation does not consider the fact that 
depressive symptoms tend to have varying characteristics. Thus, more 
research is needed regarding the extent of depressive subtypes in 
cognitive deficits in midlife, with consideration of temporal aspects. 
5.1. Strengths 
This study has several strengths. First, it used information on a suf-
ficient number of midlife participants. Second, it employed sophisti-
cated modeling utilizing a wide range of potential confounders for 
analysis. Third, by dividing depressive symptoms into two factors using 
factor analysis, a narrower definition of depressive symptoms was used. 
Fourth, sufficient MMSE data were collected for a midlife population. 
Finally, sex- and age-specific analyses elucidated associations for 
depressive subtypes with cognitive function. 
5.2. Limitations 
This study has some limitations. First, given that the design of this 
study was cross-sectional, it was difficult to make causal inferences from 
regression results. Second, although a factor analysis was utilized, 
depressive subtypes need further validation from other populations. 
Third, cognitive function assessed by MMSE reflects only the cognitive 
Table 4 
Sex- and age-specific associations between depressive subtypes and MMSE scores according to depressive subtypes quartiles.   
MMSE scores  
Men (N ¼ 1704) Women (N ¼ 3567)  
N βa (SE) p-value p for trend N βa (SE) p-value p for trend 
50 years (N ¼ 3774)           
BDI-II scores 1133 -0.02 (0.01) 0.10  2641 -0.03 (0.01) <0.01  
Melancholic scores  -0.05 (0.09) 0.58   -0.15 (0.06) 0.01  
Q1 241 ref  0.94 721 ref  0.03 
Q2 322 0.44 (0.20) 0.03  619 -0.19 (0.14) 0.19  
Q3 304 0.07 (0.20) 0.72  650 -0.15 (0.14) 0.26  
Q4 266 0.14 (0.21) 0.51  651 -0.33 (0.14) 0.02  
Somatic scores  -0.14 (0.10) 0.14   -0.18 (0.06) <0.01  
Q1 403 ref  0.22 529 ref  <0.01 
Q2 320 0.13 (0.18) 0.48  629 -0.26 (0.15) 0.10  
Q3 260 -0.09 (0.23) 0.65  701 -0.37 (0.15) 0.01*  
Q4 150 -0.12 (0.23) 0.62  782 -0.42 (0.15) <0.01*  
Over 60 years (N ¼ 1497)           
BDI-II scores 571 -0.03 (0.02) 0.03  926 -0.03 (0.01) 0.01  
Melancholic scores  -0.17 (0.14) 0.21   -0.10 (0.10) 0.32  
Q1 115 ref  0.47 241 ref  0.48 
Q2 163 0.40 (0.31) 0.21  214 0.23 (0.25) 0.36  
Q3 140 -0.01 (0.32) 0.98  223 0.04 (0.24) 0.88  
Q4 153 -0.01 (0.32) 0.98  248 -0.15 (0.24) 0.55  
Somatic scores  -0.19 (0.15) 0.20   -0.25 (0.11) 0.02  
Q1 200 ref  0.09 186 ref  0.01 
Q2 167 0.61 (0.27) 0.03  195 -0.73 (0.27) 0.01*  
Q3 112 -0.27 (0.30) 0.37  251 -0.49 (0.26) 0.05  
Q4 92 -0.28 (0.33) 0.40  294 -0.75 (0.25) <0.01*  
Notes. Coefficients were adjusted for age, socio-economic status (marital status, education, household income), life style (smoking, drinking, regular exercise), disease 
history and medication intake. 
“Melancholic” and “somatic” subtypes of BDI-II were derived from factor analysis of study participants. 
Q1: first quartile (low 25th percentile); Q2: second quartile; Q3: third quartile; Q4 fourth quartile (high 25th percentile) 
a β: Coefficients adjusted for all covariates 
* Significant in Bonferroni correction. 
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status and does not consider the executive cognitive function and indi-
vidual cognitive domains. Fourth, BDI-II was based on self-reports, and 
it was not designed to confirm a diagnosis of major depressive disorders. 
Fifth, executive cognitive dysfunction was a common symptom of major 
depressive disorders. Sixth, we only utilized screening tools of major 
depressive disorders and dementia, not diagnostic information from a 
physician. Finally, due to the lack of information, we could not consider 
the history of psychiatric disorders and medication use. 
6. Conclusion 
This study showed varying associations for depressive subtypes 
(melancholic and somatic factors) with cognitive function assessed by 
the MMSE in general midlife participants. Among these depressive 
subtypes, we observed a trends of an association between the somatic 
factor and cognitive deficits in older women, but not men, after con-
trolling for covariates. Given this heterogeneity, characterization of the 
depressive subtypes according to sex and age may improve our under-
standing of how each depressive symptom is associated differently with 
cognitive deficits in midlife. 
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